Pharmacological Reviews xPharm- The Comprehensive Pharmacology Reference
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     



0031-6997/04/5604-515-548$7.00
Pharmacol Rev 56:515-548, 2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barnes, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barnes, P. J.

Article

Mediators of Chronic Obstructive Pulmonary Disease

Peter J. Barnes

National Heart and Lung Institute, Imperial College, London, United Kingdom

Abstract
I. Introduction
II. Chronic Obstructive Pulmonary Disease as an Inflammatory Disease
    A. What is Chronic Obstructive Pulmonary Disease?
    B. Differences from Asthma
    C. Inflammatory Cells
III. Lipid Mediators
    A. Prostanoids
    B. Leukotrienes
    C. Platelet-Activating Factor
IV. Reactive Oxygen Species
    A. Formation
    B. Antioxidants
    C. Evidence for Increased Oxidative Stress
    D. Effects on Airway Function
    E. Effects of Antioxidants
V. Nitric Oxide
    A. Formation
    B. Inhibition
VI. Peptide Mediators
    A. Endothelins
    B. Bradykinin
    C. Tachykinins
    D. Complement Fragments
VII. Chemokines
    A. Interleukin-8
    B. Growth-Related Oncogene-{alpha}
    C. Epithelial Cell-Derived Neutrophil-Activating Peptide-78
    D. CXC3 Chemokines
    E. Monocyte Chemoattractant Protein-1
    F. Macrophage Inflammatory Protein
    G. Eosinophil-Selective Chemokines
    H. Lymphocyte-Selective Chemokines
    I. Dendritic Cell-Selective Chemokines
    J. CX3C Chemokines
VIII. Cytokines
    A. Tumor Necrosis Factor-{alpha}
    B. Interleukin-1{beta}
    C. Interleukin-6
    D. Interleukin-9
    E. Granulocyte-Macrophage Colony Stimulating Factor
    F. Interleukin-10
    G. Interleukin-12
    H. Interleukin-13
    I. Interleukin-17
    J. Interferon-{gamma}
IX. Growth Factors
    A. Transforming Growth Factors
    B. Epidermal Growth Factor
    C. Vascular-Endothelial Growth Factor
    D. Fibroblast Growth Factors
X. Proteases
    A. Neutrophil Elastase
    B. Other Serine Proteases
    C. Cysteine Proteases
    D. Matrix Metalloproteinases
    E. Antiproteases
XI. Conclusions
Abstract

Chronic obstructive pulmonary disease (COPD) is a major and increasing global health problem that is now a leading cause of death. COPD is associated with a chronic inflammatory response, predominantly in small airways and lung parenchyma, which is characterized by increased numbers of macrophages, neutrophils, and T lymphocytes. The inflammatory mediators involved in COPD have not been clearly defined, in contrast to asthma, but it is now apparent that many lipid mediators, inflammatory peptides, reactive oxygen and nitrogen species, chemokines, cytokines, and growth factors are involved in orchestrating the complex inflammatory process that results in small airway fibrosis and alveolar destruction. Many proteases are also involved in the inflammatory process and are responsible for the destruction of elastin fibers in the lung parenchyma, which is the hallmark of emphysema. The identification of inflammatory mediators and understanding their interactions is important for the development of anti-inflammatory treatments for this important disease.


Address correspondence to: P. J. Barnes, National Heart and Lung Institute, Imperial College School of Medicine, Dovehouse St, London SW3 6LY, United Kingdom. E-mail: p.j.barnes{at}imperial.ac.uk




This article has been cited by other articles:


Home page
J. Immunol.Home page
S. Letuve, A. Kozhich, N. Arouche, M. Grandsaigne, J. Reed, M.-C. Dombret, P. A. Kiener, M. Aubier, A. J. Coyle, and M. Pretolani
YKL-40 Is Elevated in Patients with Chronic Obstructive Pulmonary Disease and Activates Alveolar Macrophages
J. Immunol., October 1, 2008; 181(7): 5167 - 5173.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
D. Malhotra, R. Thimmulappa, A. Navas-Acien, A. Sandford, M. Elliott, A. Singh, L. Chen, X. Zhuang, J. Hogg, P. Pare, et al.
Decline in NRF2-regulated Antioxidants in Chronic Obstructive Pulmonary Disease Lungs Due to Loss of Its Positive Regulator, DJ-1
Am. J. Respir. Crit. Care Med., September 15, 2008; 178(6): 592 - 604.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. C. Morissette, G. Vachon-Beaudoin, J. Parent, J. Chakir, and J. Milot
Increased p53 Level, Bax/Bcl-xL Ratio, and TRAIL Receptor Expression in Human Emphysema
Am. J. Respir. Crit. Care Med., August 1, 2008; 178(3): 240 - 247.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
I Sabroe, L C Parker, P M A Calverley, S K Dower, and M K B Whyte
Pathological networking: a new approach to understanding COPD
Postgrad. Med. J., May 1, 2008; 84(991): 259 - 264.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. M. O'Rourke, E. Y. Wang, A. Miller, E. M. Podar, K. Scheyhing, L. Huang, C. Kessler, H. Gao, H.-T. Ton-Nu, M. T. MacDonald, et al.
Anti-Inflammatory Effects of LJP 1586 [Z-3-Fluoro-2-(4-methoxybenzyl)allylamine Hydrochloride], an Amine-Based Inhibitor of Semicarbazide-Sensitive Amine Oxidase Activity
J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 867 - 875.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Doz, N. Noulin, E. Boichot, I. Guenon, L. Fick, M. Le Bert, V. Lagente, B. Ryffel, B. Schnyder, V. F. J. Quesniaux, et al.
Cigarette Smoke-Induced Pulmonary Inflammation Is TLR4/MyD88 and IL-1R1/MyD88 Signaling Dependent
J. Immunol., January 15, 2008; 180(2): 1169 - 1178.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
C. A. Feghali-Bostwick, A. S. Gadgil, L. E. Otterbein, J. M. Pilewski, M. W. Stoner, E. Csizmadia, Y. Zhang, F. C. Sciurba, and S. R. Duncan
Autoantibodies in Patients with Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., January 15, 2008; 177(2): 156 - 163.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. J. Tudhope, T. K. Finney-Hayward, A. G. Nicholson, R. J. Mayer, M. S. Barnette, P. J. Barnes, and L. E. Donnelly
Different Mitogen-Activated Protein Kinase-Dependent Cytokine Responses in Cells of the Monocyte Lineage
J. Pharmacol. Exp. Ther., January 1, 2008; 324(1): 306 - 312.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
I. Sabroe, L. C. Parker, S. K. Dower, and M. K. B. Whyte
Practical and Conceptual Models of Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, December 1, 2007; 4(8): 606 - 610.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
F. Facchinetti, F. Amadei, P. Geppetti, F. Tarantini, C. Di Serio, A. Dragotto, P. M. Gigli, S. Catinella, M. Civelli, and R. Patacchini
{alpha},beta-Unsaturated Aldehydes in Cigarette Smoke Release Inflammatory Mediators from Human Macrophages
Am. J. Respir. Cell Mol. Biol., November 1, 2007; 37(5): 617 - 623.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
T. Yamagata, H. Sugiura, T. Yokoyama, S. Yanagisawa, T. Ichikawa, K. Ueshima, K. Akamatsu, T. Hirano, M. Nakanishi, Y. Yamagata, et al.
Overexpression of CD-11b and CXCR1 on Circulating Neutrophils: Its Possible Role in COPD
Chest, September 1, 2007; 132(3): 890 - 899.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
I. Sabroe, L. C Parker, P. M A Calverley, S. K Dower, and M. K B Whyte
Pathological networking: a new approach to understanding COPD
Thorax, August 1, 2007; 62(8): 733 - 738.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
D. L. DeMeo, C. P. Hersh, E. A. Hoffman, A. A. Litonjua, R. Lazarus, D. Sparrow, J. O. Benditt, G. Criner, B. Make, F. J. Martinez, et al.
Genetic Determinants of Emphysema Distribution in the National Emphysema Treatment Trial
Am. J. Respir. Crit. Care Med., July 1, 2007; 176(1): 42 - 48.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
P. J. Barnes
Unexpected Failure of Anti-Tumor Necrosis Factor Therapy in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., May 1, 2007; 175(9): 866 - 867.
[Full Text] [PDF]


Home page
ThoraxHome page
H. Fehrenbach, G. Zimmermann, E. Starke, V. A Bratu, D. Conrad, A. O Yildirim, and A. Fehrenbach
Nitrogen dioxide induces apoptosis and proliferation but not emphysema in rat lungs
Thorax, May 1, 2007; 62(5): 438 - 446.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
T. Parimon, J. W. Chien, C. L. Bryson, M. B. McDonell, E. M. Udris, and D. H. Au
Inhaled Corticosteroids and Risk of Lung Cancer among Patients with Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., April 1, 2007; 175(7): 712 - 719.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. R. Beaty, C. E. Rose Jr., and S.-s. J. Sung
Diverse and Potent Chemokine Production by Lung CD11bhigh Dendritic Cells in Homeostasis and in Allergic Lung Inflammation
J. Immunol., February 1, 2007; 178(3): 1882 - 1895.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
T Hirano, T Yamagata, M Gohda, Y Yamagata, T Ichikawa, S Yanagisawa, K Ueshima, K Akamatsu, M Nakanishi, K Matsunaga, et al.
Inhibition of reactive nitrogen species production in COPD airways: comparison of inhaled corticosteroid and oral theophylline
Thorax, September 1, 2006; 61(9): 761 - 766.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
A. Gadgil, X. Zhu, F. C. Sciurba, and S. R. Duncan
Altered T-Cell Phenotypes in Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, August 1, 2006; 3(6): 487 - 488.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
P. J. Barnes
Against the dutch hypothesis: asthma and chronic obstructive pulmonary disease are distinct diseases.
Am. J. Respir. Crit. Care Med., August 1, 2006; 174(3): 240 - 243.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
G. Caramori and A. Papi
Smoking history effect on peripheral lung inflammation and gene transcription in chronic obstructive pulmonary disease.
Am. J. Respir. Crit. Care Med., July 1, 2006; 174(1): 2 - 3.
[Full Text] [PDF]


Home page
Eur Respir JHome page
A. Zandvoort, Y. M. van der Geld, M. R. Jonker, J. A. Noordhoek, J. T. W. M. Vos, J. Wesseling, H. F. Kauffman, W. Timens, and D. S. Postma
High ICAM-1 gene expression in pulmonary fibroblasts of COPD patients: a reflection of an enhanced immunological function
Eur. Respir. J., July 1, 2006; 28(1): 113 - 122.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
P. J. Barnes, B. Chowdhury, S. A. Kharitonov, H. Magnussen, C. P. Page, D. Postma, and M. Saetta
Pulmonary Biomarkers in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., July 1, 2006; 174(1): 6 - 14.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
P T G Elkington and J S Friedland
Matrix metalloproteinases in destructive pulmonary pathology
Thorax, March 1, 2006; 61(3): 259 - 266.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
K. Varani, G. Caramori, F. Vincenzi, I. Adcock, P. Casolari, E. Leung, S. MacLennan, S. Gessi, S. Morello, P. J. Barnes, et al.
Alteration of Adenosine Receptors in Patients with Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., February 15, 2006; 173(4): 398 - 406.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
L. M. Butler, W.-P. Koh, H.-P. Lee, M. Tseng, M. C. Yu, and S. J. London
Prospective Study of Dietary Patterns and Persistent Cough with Phlegm among Chinese Singaporeans
Am. J. Respir. Crit. Care Med., February 1, 2006; 173(3): 264 - 270.
[Abstract] [Full Text] [PDF]


Home page
ERRHome page
E. D. Bateman
Improving inhaler use in COPD and the role of patient preference
Eur. Respir. Rev., December 1, 2005; 14(96): 85 - 88.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
Y. Chiba, M. Murata, H. Ushikubo, Y. Yoshikawa, A. Saitoh, H. Sakai, J. Kamei, and M. Misawa
Effect of Cigarette Smoke Exposure In Vivo on Bronchial Smooth Muscle Contractility In Vitro in Rats
Am. J. Respir. Cell Mol. Biol., December 1, 2005; 33(6): 574 - 581.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition
Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics